Suppr超能文献

激动剂结合核受体的共抑制因子。

Corepressors of agonist-bound nuclear receptors.

作者信息

Gurevich Igor, Flores Anthony M, Aneskievich Brian J

机构信息

Graduate Program in Pharmacology/Toxicology, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.

出版信息

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. doi: 10.1016/j.taap.2007.05.019. Epub 2007 Jun 14.

Abstract

Nuclear receptors (NRs) rely on coregulator proteins to modulate transcription of target genes. NR coregulators can be broadly subdivided into coactivators which potentiate transcription and corepressors which silence gene expression. The prevailing view of coregulator action holds that in the absence of agonist the receptor interacts with a corepressor via the corepressor nuclear receptor (CoRNR, "corner") box motifs within the corepressor. Upon agonist binding, a conformational change in the receptor causes the shedding of corepressor and the binding of a coactivator which interacts with the receptor via NR boxes within the coregulator. This view was challenged with the discovery of RIP140 which acts as a NR corepressor in the presence of agonist and utilizes NR boxes. Since then a number of other corepressors of agonist-bound NRs have been discovered. Among them are LCoR, PRAME, REA, MTA1, NSD1, and COPR1 Although they exhibit a great diversity of structure, mechanism of repression and pathophysiological function, these corepressors frequently have one or more NR boxes and often recruit histone deacetylases to exert their repressive effects. This review highlights these more recently discovered corepressors and addresses their potential functions in transcription regulation, disease pharmacologic responses and xenobiotic metabolism.

摘要

核受体(NRs)依靠共调节蛋白来调节靶基因的转录。NR共调节蛋白可大致分为增强转录的共激活因子和使基因表达沉默的共抑制因子。关于共调节蛋白作用的主流观点认为,在没有激动剂的情况下,受体通过共抑制因子内的共抑制因子核受体(CoRNR,“转角”)框基序与共抑制因子相互作用。激动剂结合后,受体内的构象变化导致共抑制因子脱落,以及与共调节蛋白内NR框相互作用的共激活因子的结合。RIP140的发现对这一观点提出了挑战,RIP140在激动剂存在的情况下作为NR共抑制因子起作用,并利用NR框。从那时起,又发现了许多其他与激动剂结合的NR共抑制因子。其中包括LCoR、PRAME、REA、MTA1、NSD1和COPR1。尽管它们在结构、抑制机制和病理生理功能上表现出很大的多样性,但这些共抑制因子通常有一个或多个NR框,并且经常招募组蛋白脱乙酰酶来发挥其抑制作用。这篇综述重点介绍了这些最近发现的共抑制因子,并探讨了它们在转录调控、疾病药理反应和外源性物质代谢中的潜在功能。

相似文献

1
Corepressors of agonist-bound nuclear receptors.激动剂结合核受体的共抑制因子。
Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. doi: 10.1016/j.taap.2007.05.019. Epub 2007 Jun 14.
3
Nuclear receptor repression: regulatory mechanisms and physiological implications.核受体抑制:调控机制与生理意义。
Prog Mol Biol Transl Sci. 2009;87:235-59. doi: 10.1016/S1877-1173(09)87007-5. Epub 2009 Oct 7.
6
Molecular dynamics simulations for human CAR inverse agonists.人类 CAR 反向激动剂的分子动力学模拟。
J Chem Inf Model. 2012 Feb 27;52(2):457-64. doi: 10.1021/ci200432k. Epub 2012 Jan 25.
8
Androgen receptor corepressors: an overview.雄激素受体共抑制因子:概述
Prostate. 2005 May 1;63(2):117-30. doi: 10.1002/pros.20170.

引用本文的文献

4
The PPAR Pocket: Renewed Opportunities for Drug Development.PPAR 口袋:药物研发的新机遇
PPAR Res. 2020 Jul 1;2020:9657380. doi: 10.1155/2020/9657380. eCollection 2020.

本文引用的文献

2
Negative regulation of hormone signaling by RIP140.RIP140对激素信号的负调控
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):51-9. doi: 10.1016/j.jsbmb.2006.09.005. Epub 2006 Oct 23.
7
Transcriptional regulation of the human pregnane-X receptor.
Drug Metab Rev. 2006;38(1-2):31-49. doi: 10.1080/03602530600569810.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验